Citation: Bm. Sadler et al., Pharmacokinetics and safety of amprenavir and ritonavir following multiple-dose, co-administration to healthy volunteers, AIDS, 15(8), 2001, pp. 1009-1018
Authors:
Sadler, BM
Chittick, GE
Polk, RE
Slain, D
Kerkering, TM
Studenberg, SD
Lou, Y
Moore, KHP
Woolley, JL
Stein, DS
Citation: Bm. Sadler et al., Metabolic disposition and pharmacokinetics of [C-14]-amprenavir, a human immunodeficiency virus type 1 (HIV-1) protease inhibitor, administered as a single oral dose to healthy male subjects, J CLIN PHAR, 41(4), 2001, pp. 386-396
Citation: Bm. Sadler et al., In vivo effect of alpha(1)-acid glycoprotein on pharmacokinetics of amprenavir, a human immunodeficiency virus protease inhibitor, ANTIM AG CH, 45(3), 2001, pp. 852-856
Authors:
Polk, RE
Brophy, DF
Israel, DS
Patron, R
Sadler, BM
Chittick, GE
Symonds, WT
Lou, Y
Kristoff, D
Stein, DS
Citation: Re. Polk et al., Pharmacokinetic interaction between amprenavir and rifabutin or rifampin in healthy males, ANTIM AG CH, 45(2), 2001, pp. 502-508
Authors:
Sadler, BM
Gillotin, C
Lou, Y
Eron, JJ
Lang, W
Haubrich, R
Stein, DS
Citation: Bm. Sadler et al., Pharmacokinetic study of human immunodeficiency virus protease inhibitors used in combination with amprenavir, ANTIM AG CH, 45(12), 2001, pp. 3663-3668
Citation: Bm. Sadler et al., Pharmacokinetic and pharmacodynamic study of the human immunodeficiency virus protease inhibitor amprenavir after multiple oral dosing, ANTIM AG CH, 45(1), 2001, pp. 30-37
Authors:
Veronese, L
Rautaureau, J
Sadler, BM
Gillotin, C
Petite, JP
Pillegand, B
Delvaux, M
Masliah, C
Fosse, S
Lou, Y
Stein, DS
Citation: L. Veronese et al., Single-dose pharmacokinetics of amprenavir, a human immunodeficiency virustype 1 protease inhibitor, in subjects with normal or impaired hepatic function, ANTIM AG CH, 44(4), 2000, pp. 821-826
Authors:
Brophy, DF
Israel, DS
Pastor, A
Gillotin, C
Chittick, GE
Symonds, WT
Lou, Y
Sadler, BM
Polk, RE
Citation: Df. Brophy et al., Pharmacokinetic interaction between amprenavir and clarithromycin in healthy male volunteers, ANTIM AG CH, 44(4), 2000, pp. 978-984
Authors:
Polk, RE
Crouch, MA
Israel, DS
Pastor, A
Sadler, BM
Chittick, GE
Symonds, WT
Gouldin, W
Lou, Y
Citation: Re. Polk et al., Pharmacokinetic interaction between ketoconazole and amprenavir after single doses in healthy men, PHARMACOTHE, 19(12), 1999, pp. 1378-1384
Authors:
Sadler, BM
Hanson, CD
Chittick, GE
Symonds, WT
Roskell, NS
Citation: Bm. Sadler et al., Safety and pharmacokinetics of amprenavir (141W94), a human immunodeficiency virus (HIV) type 1 protease inhibitor, following oral administration of single doses to HIV-infected adults, ANTIM AG CH, 43(7), 1999, pp. 1686-1692